Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants

New Vistas In Parkinson's Disease Therapy
2012
ISBN: 978-1-4899-8754-9
Verlag: Springer US

Buch, Englisch, 178 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 295 g

Reihe: Current Topics in Neurotoxicity

The specific topic, “Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants – New Perspectives In Parkinson`S Disease Therapy,” was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson`s disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): ß-carbolines (BCs) and tetrahydroisoquinolines (TIQs). These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurorestorative, anticonvulsant and antiaddictive, substances.

In this book we are going to summarize, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of TIQs and BCs effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties.

Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility oftheir therapeutic applications in neurodegenerative diseases such as Parkinson's disease.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Rommelspacher, Hans

Antkiewicz-Michaluk, Lucyna

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie

Inhaltsverzeichnis

Two faces of 1,2,3,4-tetrahydroisoquinoline mode of action in the mammalian brain: is it an endogenous neurotoxin or a neuromodulator?.- Isoquinolines as a neurotoxins: action and molecular mechanism.- 1-Methyl-1,2,3,4-tetrahydroisoquinoline – a potent neuroprotecting agent.- 1-Methyl-1,2,3,4-tetrahydroisoquinoline and addiction: experimental studies.- Beta-carbolines as neurotoxins.- Neuroprotective ß-carbolines: occurrence, formation and biodegradation.- Beta-carbolines and neuroprotection: inhibition of monoamine oxidase.- Beta-carbolines increase the efficiency of the respiratory chain in mitochondria.- Antioxidant properties of ß-carbolines.- Restoration of neuronal functions in damaged dopamine neurons: in vitro and in vivo studies.- Prospects for new treatment options in neurodegenerative diseases.